General Information of the Compound
Compound ID |
CP0389868
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
6-[[2-[4-[(E)-2-(2,2-difluoro-12-thiophen-2-yl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaen-4-yl)ethenyl]phenoxy]acetyl]amino]-N-[2-[2-[2-[[2-hydroxy-3-(1H-indol-4-yloxy)propyl]amino]ethoxy]ethoxy]ethyl]hexanamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C46H53BF2N6O7S
|
||||||||||||||||||
Molecular Weight |
882.84
|
||||||||||||||||||
Canonical SMILES |
OC(CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(\C=C\c2ccc3C=C4C=CC(c5cccs5)=[N+]4[B-](F)(F)n23)cc1)COc1cccc2[nH]ccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C46H53BF2N6O7S/c48-47(49)54-35(14-15-36(54)30-37-16-19-42(55(37)47)44-8-5-29-63-44)13-10-34-11-17-39(18-12-34)61-33-46(58)52-21-3-1-2-9-45(57)53-24-26-60-28-27-59-25-23-50-31-38(56)32-62-43-7-4-6-41-40(43)20-22-51-41/h4-8,10-20,22,29-30,38,50-51,56H,1-3,9,21,23-28,31-33H2,(H,52,58)(H,53,57)/b13-10+
Show/Hide
|
||||||||||||||||||
InChIKey |
GBEWRSJQTLMKTO-JLHYYAGUSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor